Dermata Therapeutics Inc (NASDAQ:DRMA) — Market Cap & Net Worth
Market Cap & Net Worth: Dermata Therapeutics Inc (DRMA)
Dermata Therapeutics Inc (NASDAQ:DRMA) has a market capitalization of $4.91 Million ($4.91 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28610 globally and #5806 in its home market, demonstrating a 10.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dermata Therapeutics Inc's stock price $1.33 by its total outstanding shares 4022143 (4.02 Million). Review Dermata Therapeutics Inc (DRMA) total liabilities to assess the company's total debt and financial obligations.
Dermata Therapeutics Inc Market Cap History: 2021 to 2026
Dermata Therapeutics Inc's market capitalization history from 2021 to 2026. Data shows change from $1.68 Billion to $5.35 Million (-75.63% CAGR).
Index Memberships
Dermata Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.00% | #842 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2686 of 3165 |
Weight: Dermata Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Dermata Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dermata Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DRMA by Market Capitalization
Companies near Dermata Therapeutics Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Dermata Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #444 globally with a market cap of $62.63 Billion USD.
- UCB SA (BR:UCB): Ranked #549 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $458.99 |
| #444 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.63 Billion | $607.93 |
| #549 | UCB SA | BR:UCB | $49.68 Billion | €252.40 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €780.20 |
Dermata Therapeutics Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Dermata Therapeutics Inc's market cap moved from $1.68 Billion to $ 5.35 Million, with a yearly change of -75.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.35 Million | -42.67% |
| 2025 | $9.33 Million | +71.85% |
| 2024 | $5.43 Million | -85.25% |
| 2023 | $36.80 Million | -90.68% |
| 2022 | $394.81 Million | -76.49% |
| 2021 | $1.68 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Dermata Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.91 Million USD |
| MoneyControl | $4.91 Million USD |
| MarketWatch | $4.91 Million USD |
| marketcap.company | $4.91 Million USD |
| Reuters | $4.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dermata Therapeutics Inc
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in… Read more